Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0C2YZ
|
|||
| Drug Name |
67Cu-SARTATE
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Neuroblastoma [ICD-11: 2D11.2; ICD-9: 194] | Phase 1/2 | [1] | |
| Company |
Clarity Pharmaceuticals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04023331) 67Cu-SARTATE Peptide Receptor Radionuclide Therapy Administered to Pediatric Patients With High-Risk Neuroblastoma. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.